Based on the revised Commission Decision C(2016) 7553, important modifications on unit costs for clinical studies in H2020 SC1have to be taken into account:
- possibility to use different reimbursement methods (actual or unit costs)
- conditions under which the unit costs can be modified during the implementation of the action
- more consistent use of the term i) 'patient or study participant' and ii) 'beneficiaries and third parties'
These modifications allow for significant additional flexibility with regards to the use of unit costs and will facilitate the use of unit costs in clinical studies.
Details and explanation can be found in the updated Fit for Health 2.0 Factsheet on Clinical trials .